⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11063545 | 1.00 | — | — | |
| SCHEMBL9777662 | 0.76 | — | — | |
| SCHEMBL10745821 | 0.71 | — | — | |
| SCHEMBL7106992 | 0.71 | — | — | |
| SCHEMBL9823953 | 0.70 | — | — | |
| SCHEMBL9823784 | 0.70 | — | — | |
| SCHEMBL11037243 | 0.69 | — | — | |
| SCHEMBL10763563 | 0.67 | — | — | |
| SCHEMBL7292397 | 0.67 | — | — | |
| SCHEMBL191190 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4501890-A | ANTIDEPRESSANTS, HYPOTENSIVE AND ANTISECRETORY AGENTS, PROLACTIN INHIBITOR AND TREATMENT OF PARKINSONS DISEASE | ELI LILLY AND COMPANY (US) | 1985-02-26 | — | — | US | claimed |
| US-7226910-B2 | Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists | VIVUS, INC. (US) | 2007-06-05 | — | — | US | disclosed |
| WO-2006127057-A1 | NON-SYSTEMATIC VAGINAL ADMINISTRATION OF ESTROGEN AND AN ANDROGEN FOR THE TREATMENT OF SEXUAL DYSFUNCTION | LYLE CORPORATE DRVELOPMENT, INC. (US) | 2006-11-30 | — | — | WO | disclosed |
| EP-1418920-A4 | AS-NEEDED ADMINISTRATION OF ORALLY ACTIVE ANDROGENIC AGENTS TO ENHANCE FEMALE SEXUAL DESIRE AND RESPONSIVENESS | VIVUS INC (US) | 2006-10-04 | — | — | EP | disclosed |
| EP-1420795-A4 | AS-NEEDED ADMINISTRATION OF AN ANDROGENIC AGENT TO ENHANCE FEMALE SEXUAL DESIRE AND RESPONSIVENESS | VIVUS INC (US) | 2006-09-06 | — | — | EP | disclosed |
| US-20060041021-A1 | Treatment of female sexual dysfunction with vasoactive intestinal polypeptide agonists | VIVUS, INC. (US) | 2006-02-23 | — | — | US | disclosed |
| US-20050070516-A1 | As-needed administration of an androgenic agent to enhance female desire and responsiveness | VIVUS INC. (US) | 2005-03-31 | — | — | US | disclosed |
| EP-1420795-A1 | AS-NEEDED ADMINISTRATION OF AN ANDROGENIC AGENT TO ENHANCE FEMALE SEXUAL DESIRE AND RESPONSIVENESS | Vivus, Inc. (US) | 2004-05-26 | — | — | EP | disclosed |
| EP-1418920-A1 | AS-NEEDED ADMINISTRATION OF ORALLY ACTIVE ANDROGENIC AGENTS TO ENHANCE FEMALE SEXUAL DESIRE AND RESPONSIVENESS | Vivus, Inc. (US) | 2004-05-19 | — | — | EP | disclosed |
| US-20030207852-A1 | Treatment of female sexual dysfunction | PLACE VIRGIL A (US) | 2003-11-06 | — | — | US | disclosed |
| US-6306841-B1 | NITROVASODILATOR SELECTED FROM SODIUM NITROPRUSSIDE, DIAZENIUM DIOLATE MOLSIDOMINE, LINSIDOMINE CHLORHYDRATE, S-NITROSOTHIOLS, ORGANIC NITRATES, PHARMACOLOGICALLY ACCEPTABLE SALTS, | ASIVI, LLC | 2001-10-23 | — | — | US | disclosed |
| US-6294550-B1 | ADMINISTERING A VASOACTIVE AGENT FROM ERGOTAMINE DRUG | ASIVI, LLC | 2001-09-25 | — | — | US | disclosed |
| EP-1027057-A1 | TREATMENT OF FEMALE SEXUAL DYSFUNCTION | Asivi, LLC (US) | 2000-08-16 | — | — | EP | disclosed |
| WO-1999021562-A1 | TREATMENT OF FEMALE SEXUAL DYSFUNCTION | ASIVI, LLC (US) | 1999-05-06 | — | — | WO | disclosed |
| EP-0138417-B1 | 2-SUBSTITUTED PYRIMIDOHEXAHYDROQUINOLINES | ELI LILLY AND COMPANY (US) | 1990-03-14 | — | — | EP | disclosed |
| EP-0171277-A2 | Improvements in or relating to tricycling quinoline derivatives | ELI LILLY AND COMPANY (US) | 1986-02-12 | — | — | EP | disclosed |
| US-4537964-A | Method of preparing permissibly-substituted 1H(and 2H)pyrazolo[3,4-g]quinolines; pyrimido[4,5,g]quinolines; thiazolo[4,5,g]quinolines and intermediates therefore | ELI LILLY AND COMPANY (US) | 1985-08-27 | — | — | US | disclosed |
| US-4537964-A | Method of preparing permissibly-substituted 1H(and 2H)pyrazolo[3,4-g]quinolines; pyrimido[4,5,g]quinolines; thiazolo[4,5,g]quinolines and intermediates therefore | ELI LILLY AND COMPANY (US) | 1985-08-27 | — | — | US | disclosed |
| US-4521421-A | USING 2-AMINO-OCTAHYDROPYRIMIDO(4,5-G)QUINOLINE COMPOUND | ELI LILLY AND COMPANY (US) | 1985-06-04 | — | — | US | disclosed |
| EP-0142920-A2 | 6-Oxodecahydroquinolines and process for their preparation | ELI LILLY AND COMPANY (US) | 1985-05-29 | — | — | EP | disclosed |